Receipt of the observation letter from BSE Limited conveying ''no adverse observations'' in relation to the Scheme of Amalgamation of Dr. Agarwal''s Eye Hospital Limited and Dr. Agarwal''s Health Care Limited and their respective shareholders and creditors.
Dr. Agarwal's Eye Hospital Limited Press Release Feb 17 2026
Filed with BSE · · 5 pages · English
Summary by 6ix AI
Dr. Agarwal's Eye Hospital Limited has filed an intimation regarding the receipt of an observation letter from BSE Limited, indicating no adverse observations related to the proposed amalgamation scheme with Dr. Agarwal's Health Care Limited. The scheme is subject to necessary statutory and regulatory approvals, including those from shareholders and the National Company Law Tribunal.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Dr. Agarwal'S Eye Hospital Limited on 6ix
Earlier from Dr. Agarwal'S Eye Hospital
- Dr. Agarwal's Eye Hospital Limited Press Release Feb 03 2026
- Dr. Agarwal's Eye Hospital Limited Press Release Jan 12 2026
- Dr. Agarwal's Eye Hospital Limited Press Release Dec 26 2025
- Dr. Agarwal's Eye Hospital Limited Press Release Oct 30 2025
- Dr. Agarwal's Eye Hospital Limited Press Release Oct 27 2025
Later from Dr. Agarwal'S Eye Hospital
- Dr. Agarwal's Eye Hospital Limited Press Release Feb 23 2026
- Dr. Agarwal's Eye Hospital Limited Press Release Apr 07 2026
- Dr. Agarwal's Eye Hospital Limited Press Release Apr 21 2026
- Dr. Agarwal's Eye Hospital Limited Press Release May 20 2026
- Dr. Agarwal's Eye Hospital Limited Press Release Jun 01 2026
Follow Dr. Agarwal'S Eye Hospital into a list and get an email when it puts out news.
Follow Dr. Agarwal'S Eye Hospital